Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling.
Many anticancer drugs, such as doxorubicin (DXR), intercalate into nuclear DNA of cancer cells, thereby inhibiting their growth. However, it is not well understood how such drugs interact with mitochondrial DNA (mtDNA). Using cell and molecular studies of cultured cells, we show that DXR and other D...
Main Authors: | Ashley, N, Poulton, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2009
|
Registos relacionados
-
In Vitro-Reconstituted Nucleoids Can Block Mitochondrial DNA Replication and Transcription
Por: Géraldine Farge, et al.
Publicado em: (2014-07-01) -
Modulation of mitochondrial nucleoid structure during aging and by mtDNA content in Drosophila
Por: Li-jie Wang, et al.
Publicado em: (2021-06-01) -
Inactivity of Peptidase ClpP Causes Primary Accumulation of Mitochondrial Disaggregase ClpX with Its Interacting Nucleoid Proteins, and of mtDNA
Por: Jana Key, et al.
Publicado em: (2021-11-01) -
Nucleoid remodeling during environmental adaptation is regulated by HU-dependent DNA bundling
Por: Soumya G. Remesh, et al.
Publicado em: (2020-06-01) -
Nucleosomal DNA sequence-dependent properties, targeting by novel platinum-intercalator compounds, and interactions with the p53 transcription factor
Por: Chua, Eugene Yue Dao
Publicado em: (2015)